The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 246.00
Bid: 260.00
Ask: 270.00
Change: -14.00 (-5.38%)
Spread: 10.00 (3.846%)
Open: 260.00
High: 265.00
Low: 246.00
Prev. Close: 260.00
TRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

7 Mar 2024 11:00

RNS Number : 9982F
Triad Group Plc
07 March 2024
 

Legal Entity Identifier (LEI) No. 213800MDNBFVEQEN1G84

 

Triad Group Plc

 

Trading Update

 

In my overview of results dated 20th December 2023, I said "I personally have never felt so confident and enthusiastic about the state and prospects of the Company for more than 20 years" and "I believe that we are at the beginning of a period of increasing major success and growth". I am delighted to confirm that both these statements are proving to be more than amply justified.

Since 20th December, we have continued to win major and long-term pieces of new business. We returned to profit in November and, apart from the Christmas/New Year holiday period, have been on a strongly rising trajectory ever since. Cash flow, as normal, is following closely behind the profit trend. We have been nominated for more national awards. Our recruitment process is operating at full steam ahead with great success. I should point out that the costs of setting up the new projects and hiring will be absorbed in the fourth quarter; however, this will enable us to get off to a flying start for our new financial year beginning in April. I shall provide a much more extensive account of developments in my statement accompanying the full year results.

 

Dr J C Rigg

Executive Chairman, Triad Group Plc

7 March 2024

 

Zeus Capital Limited

Alexandra Campbell-Harris

Tel: 020 7614 5900

 

 

The information contained in this announcement is deemed by the Company to constitute inside information as stipulated under Article 7 of the Market Abuse Regulations (EU) No 596/2014. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKOBQCBKKQNK
Date   Source Headline
14th Mar 20243:00 pmRNSBlock listing Interim Review
7th Mar 202411:00 amRNSTrading Statement
29th Feb 20242:00 pmRNSTotal Voting Rights
3rd Jan 202411:43 amRNSTotal Voting Rights
21st Dec 20231:00 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSHalf-year Report
14th Sep 202312:00 pmRNSBlock listing Six Monthly Return
27th Jul 20231:30 pmRNSResult of AGM
25th Jul 20233:00 pmRNSTotal Voting Rights
4th Jul 20236:00 pmRNSCorrection - Dividend Declaration
4th Jul 20233:00 pmRNSDividend Declaration
4th Jul 20233:00 pmRNSNotice of AGM
3rd Jul 202312:00 pmRNSDirector/PDMR Shareholding
30th Jun 20231:00 pmRNSDirector/PDMR Shareholding
28th Jun 20231:30 pmRNSDirectorate Change
28th Jun 20231:30 pmRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector dealings
12th Jun 20237:00 amRNSAnnual Financial Report
1st Jun 20237:00 amRNSDirectorate Change
9th May 20234:30 pmRNSDirector/PDMR Shareholding
31st Mar 202310:30 amRNSChange of Broker
14th Mar 20233:00 pmRNSBlock listing Review
28th Feb 202311:00 amRNSHolding(s) in Company
15th Feb 202312:00 pmRNSHolding(s) in Company
18th Jan 20234:40 pmRNSSecond Price Monitoring Extn
18th Jan 20234:35 pmRNSPrice Monitoring Extension
18th Jan 20237:00 amRNSTrading Statement
22nd Dec 20229:00 amRNSTotal Voting Rights
1st Dec 20227:00 amRNSHalf-year Report
10th Nov 202212:00 pmRNSTotal Voting Rights
14th Sep 202212:00 pmRNSBlock Listing Six Monthly Review
12th Sep 202212:00 pmRNSHolding(s) in Company
8th Sep 20224:30 pmRNSDirector/PDMR Shareholding
21st Jul 202210:00 amRNSResult of AGM
15th Jul 20229:00 amRNSTotal Voting Rights
11th Jul 20225:00 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSNotice of AGM
28th Jun 20227:00 amRNSDividend Declaration
9th Jun 20225:00 pmRNSTotal Voting Rights
7th Jun 202212:30 pmRNSHolding(s) in Company
1st Jun 20223:00 pmRNSHolding(s) in Company
31st May 20224:30 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSHolding(s) in Company
26th May 20227:00 amRNSAnnual Financial Report
12th Apr 20224:30 pmRNSHolding(s) in Company
31st Mar 20224:30 pmRNSGrant of Restrictive Share Units
25th Mar 20224:45 pmRNSResult of Meeting
14th Mar 20224:00 pmRNSBlock listing six monthly return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.